Literature DB >> 8263327

Monoclonal antibodies against the protein core and glycosaminoglycan side chain of glomerular basement membrane heparan sulfate proteoglycan: characterization and immunohistological application in human tissues.

J van den Born1, L P van den Heuvel, M A Bakker, J H Veerkamp, K J Assmann, J H Berden.   

Abstract

We raised monoclonal antibodies (MAb) against the core protein and the heparan sulfate (HS) side chain of heparan sulfate proteoglycan (HSPG) from glomerular basement membranes (GBM). Anti-HSPG-core MAb were obtained after immunization of mice with HSPG purified from human GBM and the anti-HS MAb after immunization of mice with HSPG from rat glomeruli, which crossreacted with human HS and GBM HSPG. The specificity of the MAb was demonstrated by ELISA studies, Western blotting, inhibition experiments, and indirect immunofluorescence (IF) on kidney cryostat sections pre-treated with glycosaminoglycan (GAG)-degrading enzymes. Indirect IF on normal human kidney tissue showed prominent GBM staining for both MAb, with variable staining of the other renal basement membranes (BMs). By indirect immunoelectron microscopy (IEM), most intense staining was observed at the endothelial side of the GBM for both MAb, although the staining patterns were not identical. Both MAb were used to localize HSPG in human tissues by indirect IF. They bound to antigens present in the BMs of most tissues examined, including those of epithelia and endothelia. Differences between both MAb were observed for BMs of muscle cells, since the anti-HSPG core protein MAb (JM-72) staining was negative, whereas the anti-HS MAb (JM-403) clearly stained these structures. Comparison of our staining patterns in human tissues with the distribution of other anti-BM HSPG antibodies suggests that there are at least two types of BM HSPG, which have common epitopes on the HS side chains recognized by JM-403.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8263327     DOI: 10.1177/42.1.8263327

Source DB:  PubMed          Journal:  J Histochem Cytochem        ISSN: 0022-1554            Impact factor:   2.479


  6 in total

1.  Reduction of heparan sulphate-associated anionic sites in the glomerular basement membrane of rats with streptozotocin-induced diabetic nephropathy.

Authors:  J van den Born; A A van Kraats; M A Bakker; K J Assmann; H B Dijkman; J A van der Laak; J H Berden
Journal:  Diabetologia       Date:  1995-10       Impact factor: 10.122

2.  Agrin is a major heparan sulfate proteoglycan accumulating in Alzheimer's disease brain.

Authors:  M M Verbeek; I Otte-Höller; J van den Born; L P van den Heuvel; G David; P Wesseling; R M de Waal
Journal:  Am J Pathol       Date:  1999-12       Impact factor: 4.307

3.  Determination of heparan sulphate in kidney tissues of patients with calcium nephrolithiasis.

Authors:  V S Chan; E C Tan; M K Li
Journal:  Urol Res       Date:  1995

4.  Agrin signalling contributes to cell activation and is overexpressed in T lymphocytes from lupus patients.

Authors:  Elizabeth C Jury; Jillian Eldridge; David A Isenberg; Panagiotis S Kabouridis
Journal:  J Immunol       Date:  2007-12-01       Impact factor: 5.422

5.  Decrease of heparan sulfate staining in the glomerular basement membrane in murine lupus nephritis.

Authors:  M C van Bruggen; K Kramers; M N Hylkema; J van den Born; M A Bakker; K J Assmann; R J Smeenk; J H Berden
Journal:  Am J Pathol       Date:  1995-03       Impact factor: 4.307

6.  Heparanase induces a differential loss of heparan sulphate domains in overt diabetic nephropathy.

Authors:  T J M Wijnhoven; M J W van den Hoven; H Ding; T H van Kuppevelt; J van der Vlag; J H M Berden; R A Prinz; E J Lewis; M Schwartz; X Xu
Journal:  Diabetologia       Date:  2007-12-06       Impact factor: 10.122

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.